CASIA OpenIR  > 脑网络组研究中心
Blood pressure-lowering drugs and secondary prevention of cardiovascular disease: systematic review and meta-analysis
Xie, Wuxiang1,2; Zheng, Fanfan3,4; Evangelou, Evangelos2; Liu, Ou5; Yang, Zhenchun2; Chan, Queenie2; Elliott, Paul2; Wu, Yangfeng1
2018-06-01
发表期刊JOURNAL OF HYPERTENSION
卷号36期号:6页码:1256-1265
文章类型Review
摘要Objective:To systematically evaluate the efficacy of five commonly used blood pressure-lowering drugs in reducing cardiovascular events among patients with nonacute cardiovascular disease, but without heart failure.Methods:We searched PubMed, EMBASE, and Cochrane Central Register of Controlled Trials on 18 March 2017. The primary outcome was fatal and nonfatal cardiovascular events, and the secondary outcomes were all-cause death, fatal and nonfatal myocardial infarction, and stroke. Pooled risk ratios and corresponding 95% confidence intervals (CIs) were calculated using Mantel-Haenszel random-effects meta-analyses.Results:Twenty-seven randomized controlled trials with 143095 participants and a treatment duration of at least 12 months were included in our analyses. Fifteen trials enrolled patients with coronary artery disease, eight enrolled patients with cerebral artery disease, and four enrolled patients with cardiovascular disease. Of the 27 trials, 10 trials only included hypertensive patients. Compared with placebo, angiotensin-converting enzyme inhibitors (ACEIs) (risk ratio 0.85, 95% CI 0.78-0.92), angiotensin receptor blockers (risk ratio 0.92, 95% CI 0.87-0.98), and diuretics (risk ratio 0.77, 95% CI 0.66-0.90) significantly reduced the risk of cardiovascular events. Apart from this, ACEIs significantly reduced all secondary outcomes, calcium channel blockers, and diuretics reduced stroke significantly. No significant difference was found in head-to-head comparisons of each given drug class with any other class.Conclusions:Although only ACEIs have evidences showing its effect in reducing cardiovascular events and all secondary outcomes, head-to-head comparisons did not provide strong evidence in difference in the effects between these blood pressure-lowering drugs.
关键词Blood Pressure-lowering Cardiovascular Disease Meta-analysis Secondary Prevention
WOS标题词Science & Technology ; Life Sciences & Biomedicine
DOI10.1097/HJH.0000000000001720
关键词[WOS]CORONARY-ARTERY-DISEASE ; RANDOMIZED CONTROLLED-TRIAL ; CONVERTING-ENZYME-INHIBITION ; TRANSIENT ISCHEMIC ATTACK ; HIGH-RISK PATIENTS ; ATHEROSCLEROTIC VASCULAR-DISEASE ; ACUTE MYOCARDIAL-INFARCTION ; AMERICAN-HEART-ASSOCIATION ; PLACEBO-CONTROLLED TRIAL ; OUTCOME INCIDENCE
收录类别SCI
语种英语
项目资助者Newton International Fellowship from the Academy of Medical Sciences(P56804)
WOS研究方向Cardiovascular System & Cardiology
WOS类目Peripheral Vascular Disease
WOS记录号WOS:000431515500005
引用统计
文献类型期刊论文
条目标识符http://ir.ia.ac.cn/handle/173211/22035
专题脑网络组研究中心
作者单位1.Peking Univ, Clin Res Inst, Beijing, Peoples R China
2.Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England
3.Chinese Acad Sci, Inst Automat, Brainnetome Ctr, Beijing, Peoples R China
4.UCL, Inst Cognit Neurosci, London, England
5.Capital Med Univ, Beijing Lab Cardiovasc Precis Med, Anzhen Hosp, Dept Cardiovasc Surg, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Xie, Wuxiang,Zheng, Fanfan,Evangelou, Evangelos,et al. Blood pressure-lowering drugs and secondary prevention of cardiovascular disease: systematic review and meta-analysis[J]. JOURNAL OF HYPERTENSION,2018,36(6):1256-1265.
APA Xie, Wuxiang.,Zheng, Fanfan.,Evangelou, Evangelos.,Liu, Ou.,Yang, Zhenchun.,...&Wu, Yangfeng.(2018).Blood pressure-lowering drugs and secondary prevention of cardiovascular disease: systematic review and meta-analysis.JOURNAL OF HYPERTENSION,36(6),1256-1265.
MLA Xie, Wuxiang,et al."Blood pressure-lowering drugs and secondary prevention of cardiovascular disease: systematic review and meta-analysis".JOURNAL OF HYPERTENSION 36.6(2018):1256-1265.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Xie, Wuxiang]的文章
[Zheng, Fanfan]的文章
[Evangelou, Evangelos]的文章
百度学术
百度学术中相似的文章
[Xie, Wuxiang]的文章
[Zheng, Fanfan]的文章
[Evangelou, Evangelos]的文章
必应学术
必应学术中相似的文章
[Xie, Wuxiang]的文章
[Zheng, Fanfan]的文章
[Evangelou, Evangelos]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。